Impact of the COVID-19 Pandemic on Symptoms of Anxiety Disorders

Impact of the COVID-19 Pandemic on Symptoms of Anxiety Disorders - COVID-AD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022280

Enrollment

110

Registered

2020-07-13

Start date

2020-07-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F40.00 F40.01 F40.1 F41.0 F40.2

Interventions

Group 1: Questionnaire exploring the impact of the COVID-19 pandemic on anxiety patients being in therapy in our outpatient clinic or on the waiting list for cognitive behavioral therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: primary diagnosis anxiety disorder

Exclusion criteria

Exclusion criteria: suicidality, psychotic disorders, substance dependence

Design outcomes

Primary

Measure	Time frame
change of anxiety symptoms measured by evaluated questionnaires. Questionnaires: LSAS PAS Fragebogen zu COVID-19 (self made) Start of survey: 20.07.2020	—

Secondary

Measure	Time frame
mental health measured by evaluated questionnaires Questionnaires: PHQ individual questions Start of survey: 20.07.2020	—

Countries

Germany

Contacts

Public ContactAndrea Ertle

Lehrstuhl für Psychotherapie, Institut für Psychologie, Humboldt-Universität zu Berlin

andrea.ertle@hu-berlin.de(030) 2093-4833

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026